Menopause hits like a tipping point: 300 million lab tests reveal a sudden body-wide shift

Menopause has long been portrayed as a slow, drawn-out transition, a gradual winding down of the reproductive system that unfolds over many years. A new study from the Weizmann Institute of Science, published in Nature Medicine, challenges that picture in a striking way. By analyzing more than 300 million laboratory test results from over one million women in the United States and Israel, Prof. Uri Alon and his team found evidence that the female body undergoes a sharp, system-wide turning point around the time of the last menstrual period. The abrupt changes they detected extended far beyond the familiar decline in sex hormones and the end of fertility, touching measures of health across nearly every major organ system.

The scale of the analysis is what sets the study apart. The research team, led by Dr. Glen Pridham and Yoav Hayut from Alon’s lab in Weizmann’s Molecular Cell Biology Department, drew on two enormous datasets: results from the US National Health and Nutrition Examination Survey, collected over more than two decades, and medical records spanning roughly 20 years from Clalit, Israel’s largest health insurer. Datasets of this size are rarely brought to bear on menopause research, and the reason is simple: they usually lack the one piece of information that matters most for this kind of analysis, namely the age at which each woman had her final period.

That missing information creates a fundamental problem for anyone trying to pin down what happens at menopause itself. If women reach menopause at different ages, and a researcher aligns their medical records by calendar age, the true signal of the transition gets smeared across time. A sharp change that occurs at age 51 in one woman and age 54 in another looks, in the averaged data, like a gradual change stretched over several years. The apparent slowness of menopause, in other words, could partly be an artifact of the way the data are pooled rather than a property of the biology itself.

To cut through this blur, the Weizmann team borrowed an idea from an unexpected field: astronomy. Astronomers routinely sharpen images distorted by the optics of their telescopes by mathematically correcting for those distortions, a process known as deconvolution. The researchers developed a computational method inspired by this approach that removed the blurring introduced by differences in the age at which women reach menopause. Once that correction was applied, what emerged from the data was not a gentle slope but a distinct physiological turning point, a sudden shift in dozens of bodily measures concentrated around the time of the last menstrual period.

The breadth of the changes came as a surprise. Of the 90 types of laboratory tests examined, 52 showed abrupt changes at the transition, covering nearly all body systems. The affected measures included markers of bone health, liver function, kidney function, and cholesterol levels, alongside the expected shifts in sex hormones. This suggests that menopause is not confined to the reproductive axis but registers across the organism, with the end of ovarian hormone production rippling outward into metabolism, skeletal maintenance, and organ function in a coordinated and comparatively rapid way.

Two comparison groups in the data helped sharpen the interpretation. No such abrupt changes were observed in men of similar ages, indicating that the turning point is specific to the female transition rather than a general feature of aging in midlife. And among women receiving menopausal hormone therapy, the changes were less pronounced, a pattern consistent with the idea that the declining hormone levels themselves drive much of the body-wide shift. While the study’s design does not by itself establish hormone therapy as protective, the contrast offers a natural experiment hinting that supplementing the hormones lost at menopause may soften the physiological transition.

The timing of the underlying hormonal changes also proved more dramatic than expected. The sudden shifts at menopause were preceded by accelerating changes in sex hormone levels that began more than a decade before the final period, several years earlier than previous research had suggested. In practical terms, the body appears to enter a period of accelerating hormonal change in the mid-to-late thirties or early forties for many women, long before the first obvious symptoms of the transition appear. The final event at menopause, on this view, is the endpoint of a long buildup rather than the beginning of the story.

Because most of the abrupt changes identified in the study are associated with increased disease risk, the findings carry a clear message for preventive medicine. Bone loss, adverse changes in cholesterol, and declining kidney and liver measures are all modifiable risk factors, and interventions such as exercise and dietary improvement are most effective when they start early. Our study extends the window for potential preventive care to almost a decade before menopause, Alon says. That reframing turns the decade before the last period from a quiet prelude into a critical window in which women and their physicians can act on measurable, trackable changes in blood tests.

The methodological contribution may prove as consequential as the biological one. The deconvolution-style approach the team developed is not specific to menopause; it can, in principle, be applied to any large medical dataset in which a key event happens at different ages for different people, allowing researchers to recover the true sharpness of the underlying transition. More broadly, the method we developed may help study other major changes in life, such as puberty, pregnancy or the onset of disease, Alon notes. If other life transitions that look gradual in population data turn out to be sharp once the blur is removed, the study could reshape how medicine thinks about aging and disease onset more generally.

The study also involved Dr. Noa Lavi-Shoseyov and Prof. Michal Neeman of Weizmann’s Immunology and Regenerative Biology Department, Dr. Noa Hovav of the Menopause Community Center at Clalit Health Care, and Dr. Yoel Toledano of the Helen Schneider Women’s Hospital at Rabin Medical Center, with Dr. Lavi-Shoseyov additionally affiliated with the IVF Unit in the Department of Obstetrics and Gynecology at Kaplan Medical Center. Taken together, the work recasts menopause as a discrete physiological event with a long and measurable runway leading up to it. For the more than one million women whose records made the discovery possible, and for the millions more approaching the transition, the practical takeaway is that the years before menopause matter far more than has been assumed, and that routine laboratory tests, viewed through the right computational lens, can reveal a turning point in time to act on it.

Subject of Research: A computational analysis of large medical datasets revealing a sudden body-wide physiological transition at menopause

Article Title: Menopause: more than a slow change, it’s a sudden shift across the body

Article References: Menopause: more than a slow change, it’s a sudden shift across the body. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: menopause, Weizmann Institute, Nature Medicine, deconvolution, sex hormones, preventive medicine, bone health, cholesterol, hormone therapy, NHANES, Clalit, biomarkers